Clinical and epidemiological round: journals club
DOI:
https://doi.org/10.17533/udea.iatreia.v28n2a12Keywords:
fluoroquinolones, pancreatitis, peripheral nervous system diseases, sulfamethoxazole, sudden death, trimethoprim, urinalysisAbstract
In this edition of the clinical and epidemiological round, we analyze four articles relevant for clinical practice, namely: the adverse effects of some antimicrobials are studied by Etminan et al., looking for a possible association between the use of oral fluoroquinolones and the risk of peripheral neuropathy (1). Fralick et al., studied the risk of sudden death after the use of trimethoprim sulfamethoxazole (2). Bakker and collaborators make an interesting contribution about the need of nasoyeyunal catheter in patients suffering from acute pancreatitis (3). Finally, Kanegaye et al., look for the best diagnostic test for urinary infections in infants (4).
Downloads
References
(1.) Etminan M, Brophy JM, Samii A. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study. Neurology. 2014 Sep;83(14):1261-3.
(2.) Fralick M, Macdonald EM, Gomes T, Antoniou T, Hollands S, Mamdani MM, et al. Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study. BMJ. 2014 Oct;349:g6196.
(3.) Bakker OJ, van Brunschot S, van Santvoort HC, Besselink MG, Bollen TL, Boermeester MA, et al. Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med. 2014 Nov;371(21):1983-93.
(4.) Kanegaye JT, Jacob JM, Malicki D. Automated urinalysis and urine dipstick in the emergency evaluation of young febrile children. Pediatrics. 2014 Sep;134(3):523-9.
(5.) Sousa J, Alves G, Fortuna A, Falcão A. Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles. Curr Drug Saf. 2014;9(2):89-105.
(6.) Food and Drug Administration. FDA Drug Safety Communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection [Internet]. [cited 2015 Jan 3]. Available from: http://www.fda.gov/downloads/Drugs/ DrugSafety/UCM365078.pdf142
(7.) Ali AK. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis. Ann Epidemiol. 2014 Apr;24(4):279-85.
(8.) Velazquez H, Perazella MA, Wright FS, Ellison DH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993 Aug;119(4):296-301.
(9.) Alappan R, Buller GK, Perazella MA. Trimethoprimsulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem? Am J Nephrol. 1999;19(3):389-94.
(10.) Marinella MA. Trimethoprim-induced hyperkalemia: An analysis of reported cases. Gerontology. 1999 Jul-Aug;45(4):209-12.
(11.) Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. Arch Intern Med. 2010 Jun;170(12):1045-9.
(12.) Antoniou T, Gomes T, Mamdani MM, Yao Z, Hellings C, Garg AX, et al. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ. 2011Sep;343:d5228.
(13.) Besselink MG, van Santvoort HC, Renooij W, de Smet MB, Boermeester MA, Fischer K, et al. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg. 2009 Nov;250(5):712-9.
(14.) Sun JK, Mu XW, Li WQ, Tong ZH, Li J, Zheng SY. Effects of early enteral nutrition on immune function of severe acute pancreatitis patients. World J Gastroenterol. 2013 Feb;19(6):917-22.
(15.) Wereszczynska-Siemiatkowska U, Swidnicka-Siergiejko A, Siemiatkowski A, Dabrowski A. Early enteral nutrition is superior to delayed enteral nutrition for the prevention of infected necrosis and mortality in acute pancreatitis. Pancreas. 2013 May;42(4):640-6.
(16.) Oláh A, Romics L Jr. Enteral nutrition in acute pancreatitis: a review of the current evidence. World J Gastroenterol. 2014 Nov;20(43):16123-31.
(17.) Malo G, Echeverry J, Iragorri S, Gastelbondo R. Infección urinaria en niños menores de dos años: guía de práctica clínica. Sociedad colombiana de urología. Urol Colomb. 2001;36(2).
(18.) Pemberthy C, Gutierrez J, Arango N, Monsalve M, Giraldo N, Gutierrez F, et al. Aspectos clínicos y farmacoterapéuticos de la infección del tracto urinario. Revision estructurada. CES Med. 2011 Jul-Dic; 25 (2):135-52.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Iatreia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
